PCB pattern analysis as a biomarker for endocrine disruptors: where to draw the line for adverse effects?

N.W. van den Brink, A.T.C. Bosveld

    Research output: Chapter in Book/Report/Conference proceedingConference paperAcademic

    Original languageUndefined/Unknown
    Title of host publicationRIKZ/NIOB/M&T symposium endocrine disrupting compounds: wildlife and human health effects, 27 October, The Hague, 1998
    Publication statusPublished - 1998

    Cite this